This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 119/10/1386    most recent CIRCULATIONAHA.108.802918v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hamid, T. Articles by Prabhu, S. D. Search for Related Content PubMed PubMed Citation Articles by Hamid, T. Articles by Prabhu, S. D. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH Medline Plus Health Information Heart Failure Related Collections Contractile function Growth factors/cytokines Heart failure - basic studies Related Article

(Circulation. 2009;119:1386-1397.)
© 2009 American Heart Association, Inc.

Heart Failure

Divergent Tumor Necrosis Factor Receptor–Related Remodeling Responses in Heart Failure

Role of Nuclear Factor-B and Inflammatory Activation

Tariq Hamid, PhD; Yan Gu, MD, PhD; Roger V. Ortines, BS; Chhandashri Bhattacharya, MS; Guangwu Wang, MD, PhD; Yu-Ting Xuan, PhD; Sumanth D. Prabhu, MD

From the Institute of Molecular Cardiology, Department of Medicine, University of Louisville and Louisville Veterans Affairs Medical Center, Louisville, Ky.

Correspondence to Sumanth D. Prabhu, MD, Department of Medicine/Cardiovascular Medicine, University of Louisville, ACB, 3rd Floor, 550 S Jackson St, Louisville, KY 40202. E-mail sprabhu{at}louisville.edu

Received June 27, 2008; accepted December 19, 2008.

Background— Although preclinical data suggested that tumor necrosis factor- (TNF) neutralization in heart failure (HF) would be beneficial, clinical trials of TNF antagonists were paradoxically negative. We hypothesized that TNF induces opposing inflammatory and remodeling responses in HF that are TNF-receptor (TNFR) specific.

Methods and Results— HF was induced in wild-type (WT), TNFR1^–/–, and TNFR2^–/– mice via coronary ligation. Compared with WT HF, 4-week postinfarction survival was significantly improved in both TNFR1^–/– and TNFR2^–/– HF. Compared with sham, WT HF hearts exhibited significant remodeling with robust activation of nuclear factor (NF)-B, p38 mitogen-activated protein kinase, and JNK2 and upregulation of TNF, interleukin (IL)-1β, IL-6, and IL-10. Compared with WT HF, TNFR1^–/– HF exhibited (1) improved remodeling, hypertrophy, and contractile function; (2) less apoptosis; and (3) diminished NF-B, p38 mitogen-activated protein kinase, and JNK2 activation and cytokine expression. In contrast, TNFR2^–/– HF showed exaggerated remodeling and hypertrophy, increased border zone fibrosis, augmented NF-B and p38 mitogen-activated protein kinase activation, higher IL-1β and IL-6 gene expression, greater activated macrophages, and greater apoptosis. Oxidative stress and diastolic function were improved in both TNFR1^–/–and TNFR2^–/– HF. In H9c2 cardiomyocytes, sustained NF-B activation was proapoptotic, an effect dependent on TNFR1 signaling, whereas TNFR2 overexpression attenuated TNF-induced NF-B activation.

Conclusions— TNFR1 and TNFR2 have disparate and opposing effects on remodeling, hypertrophy, NF-B, inflammation, and apoptosis in HF: TNFR1 exacerbates, whereas TNFR2 ameliorates, these events. However, signaling through both receptors is required to induce diastolic dysfunction and oxidative stress. TNFR-specific effects in HF should be considered when therapeutic anti-TNF strategies are developed.

---

 

CLINICAL PERSPECTIVE

Related Article:

Clinical Summaries
Circulation 2009 119: 1353-1354. [Extract] [Full Text]

This article has been cited by other articles:

				R. Schulz and G. Heusch Tumor Necrosis Factor-{alpha} and Its Receptors 1 and 2: Yin and Yang in Myocardial Infarction? Circulation, March 17, 2009; 119(10): 1355 - 1357. [Full Text] [PDF]